Close Menu

Open Source R&D

What's the "hot new trend" in R&D? According to Bloomberg opinion columnist Alice Schroeder, it's "open source innovation," which will harness the power of crowd sourcing to come up with intelligent and inexpensive solutions to different research questions. "For corporate executives, open source innovation holds out the promise of maintaining a technological edge while lowering R&D costs," Schroeder says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.